SPATS1
geneOn this page
Also known as SPATA8FLJ25442SRSP1
Summary
SPATS1 (spermatogenesis associated serine rich 1, HGNC:22957) is a protein-coding gene on chromosome 6p21.1, encoding Spermatogenesis-associated serine-rich protein 1 (Q496A3).
At a glance
- GWAS associations: 19
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_001372081
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22957 |
| Approved symbol | SPATS1 |
| Name | spermatogenesis associated serine rich 1 |
| Location | 6p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SPATA8, FLJ25442, SRSP1 |
| Ensembl gene | ENSG00000249481 |
| Ensembl biotype | protein_coding |
| Entrez | 221409 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 nonsense_mediated_decay
ENST00000288390, ENST00000323108, ENST00000506468, ENST00000515220, ENST00000674044, ENST00000859514
RefSeq mRNA: 2 — MANE Select: NM_001372081
NM_001372081, NM_145026
CCDS: CCDS4911
Canonical transcript exons
ENST00000674044 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003468433 | 44352726 | 44352873 |
| ENSE00003527814 | 44361831 | 44361992 |
| ENSE00003535562 | 44360446 | 44360570 |
| ENSE00003573836 | 44376358 | 44376473 |
| ENSE00003613538 | 44370051 | 44370113 |
| ENSE00003626609 | 44368379 | 44368499 |
| ENSE00003757635 | 44343096 | 44343234 |
| ENSE00003896453 | 44342650 | 44342768 |
| ENSE00003897258 | 44377035 | 44380179 |
Expression profiles
Bgee: expression breadth broad, 63 present calls, max score 85.41.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0882 / max 46.9128, expressed in 26 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 68026 | 0.0571 | 20 |
| 68027 | 0.0312 | 5 |
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 85.41 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.22 | gold quality |
| left testis | UBERON:0004533 | 84.35 | gold quality |
| testis | UBERON:0000473 | 83.93 | gold quality |
| right testis | UBERON:0004534 | 83.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.81 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 71.88 | gold quality |
| islet of Langerhans | UBERON:0000006 | 59.58 | gold quality |
| fallopian tube | UBERON:0003889 | 59.12 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 51.78 | silver quality |
| cortical plate | UBERON:0005343 | 50.96 | gold quality |
| right lung | UBERON:0002167 | 47.77 | gold quality |
| prefrontal cortex | UBERON:0000451 | 46.85 | gold quality |
| endometrium | UBERON:0001295 | 46.76 | gold quality |
| bone marrow cell | CL:0002092 | 46.32 | gold quality |
| hypothalamus | UBERON:0001898 | 45.98 | gold quality |
| caudate nucleus | UBERON:0001873 | 45.86 | gold quality |
| sural nerve | UBERON:0015488 | 45.50 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.47 | gold quality |
| temporal lobe | UBERON:0001871 | 45.17 | gold quality |
| Ammon’s horn | UBERON:0001954 | 45.14 | gold quality |
| amygdala | UBERON:0001876 | 44.89 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 43.85 | gold quality |
| frontal cortex | UBERON:0001870 | 42.51 | gold quality |
| lung | UBERON:0002048 | 41.97 | gold quality |
| cerebral cortex | UBERON:0000956 | 41.90 | gold quality |
| pancreas | UBERON:0001264 | 41.70 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 41.24 | gold quality |
| brain | UBERON:0000955 | 41.09 | gold quality |
| primary visual cortex | UBERON:0002436 | 41.03 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting SPATS1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-6757-3P | 99.63 | 66.88 | 1089 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-4773 | 98.35 | 67.30 | 1710 |
| HSA-MIR-4704-3P | 98.28 | 69.33 | 1300 |
| HSA-MIR-1243 | 97.07 | 65.44 | 719 |
| HSA-MIR-6839-5P | 96.74 | 68.29 | 1088 |
| HSA-MIR-378J | 96.44 | 66.20 | 1020 |
| HSA-MIR-4296 | 96.35 | 63.55 | 1233 |
| HSA-MIR-4265 | 96.18 | 64.68 | 557 |
| HSA-MIR-4322 | 96.18 | 64.85 | 539 |
| HSA-MIR-1178-5P | 95.83 | 64.12 | 504 |
| HSA-MIR-6796-5P | 95.37 | 66.08 | 1120 |
| HSA-MIR-9901 | 84.80 | 61.80 | 26 |
Literature-anchored findings (GeneRIF, showing 1)
- Dishevelled-DEP domain interacting protein is a negative regulator of the canonical Wnt signaling. (PMID:20603214)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spats1 | ENSMUSG00000023935 |
| rattus_norvegicus | Spats1 | ENSRNOG00000019963 |
Protein
Protein identifiers
Spermatogenesis-associated serine-rich protein 1 — Q496A3 (reviewed: Q496A3)
All UniProt accessions (3): D6RF91, Q496A3, H0Y9A9
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q496A3-1 | 1 | yes |
| Q496A3-2 | 2 |
RefSeq proteins (2): NP_001359010, NP_659463 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029165 | SASRP1 | Family |
Pfam: PF15160
UniProt features (10 total): compositionally biased region 3, region of interest 2, chain 1, modified residue 1, splice variant 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q496A3-F1 | 58.12 | 0.09 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 113
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 49 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, GCANCTGNY_MYOD_Q6, TAL1ALPHAE47_01, GATA1_04, MYB_Q3, MYB_Q5_01, TGGAAA_NFAT_Q4_01, HEB_Q6, MYB_Q6, chr15q26, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, GCAAGAC_MIR431, ERR1_Q2
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
454 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATS1 | SPATA3 | Q8NHX4 | 714 |
| SPATS1 | SPACA4 | Q8TDM5 | 624 |
| SPATS1 | CAPN11 | Q9UMQ6 | 608 |
| SPATS1 | TMEM225 | Q6GV28 | 601 |
| SPATS1 | TMEM270 | Q6UE05 | 552 |
| SPATS1 | DRC5 | Q5JU00 | 551 |
| SPATS1 | FBXO36 | Q8NEA4 | 493 |
| SPATS1 | TMEM151B | Q8IW70 | 479 |
| SPATS1 | GARIN1B | Q96KD3 | 477 |
| SPATS1 | GTSF1L | Q9H1H1 | 471 |
| SPATS1 | DNAJC14 | Q6Y2X3 | 451 |
| SPATS1 | NUP210L | Q5VU65 | 449 |
| SPATS1 | UBQLN3 | Q9H347 | 438 |
| SPATS1 | PIH1D2 | Q8WWB5 | 424 |
| SPATS1 | SPATA16 | Q9BXB7 | 424 |
IntAct
84 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPATS1 | KCTD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZIC1 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | CTNNA3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | MISP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CASP6 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | CHAT | psi-mi:“MI:0915”(physical association) | 0.560 |
| CRYAA | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | ATN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| SPATS1 | EIF2S3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | ERN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | FKBP1A | psi-mi:“MI:0915”(physical association) | 0.560 |
| GRIN2C | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSPA2 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NDUFS5 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | KLK6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RAN | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | SARS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | OPTN | psi-mi:“MI:0915”(physical association) | 0.560 |
| SPATS1 | TOR1AIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UBQLN1 | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF40A | SPATS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (11): SPATS1 (Two-hybrid), SPATS1 (Two-hybrid), SPATS1 (Two-hybrid), SPATS1 (Two-hybrid), SPATS1 (Proximity Label-MS), HIST1H2BH (Proximity Label-MS), SPATS1 (Two-hybrid), SPATS1 (Two-hybrid), SPG7 (Two-hybrid), SPATS1 (Two-hybrid), SPATS1 (Two-hybrid)
ESM2 similar proteins: A0A1B0GVB3, A0A1B0GVH6, A2RRY8, A4IGV6, A6NHR8, B3DHS1, E1B9I5, O74317, O95561, P03319, P03320, P0C9Z5, P0C9Z6, P10260, P36353, P40744, P40745, Q06616, Q09280, Q09424, Q2KIL1, Q2KIR0, Q32KT7, Q32LB6, Q3T028, Q3TTI8, Q496A3, Q5NC83, Q5SQS8, Q5XIU7, Q68FQ8, Q6DFB0, Q6ZNM6, Q6ZV65, Q811V6, Q8IWA6, Q8N9R6, Q8R0E5, Q8TAL5, Q8WTQ4
Diamond homologs: A2RRY8, Q496A3, Q811V6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1995 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:96783570:C:G | donor_gain | 1.0000 |
| 15:96784151:A:AG | acceptor_gain | 1.0000 |
| 15:96784152:G:GA | acceptor_gain | 1.0000 |
| 15:96784152:GA:G | acceptor_gain | 1.0000 |
| 15:96784255:GGAAG:G | donor_gain | 1.0000 |
| 15:96784256:GAAG:G | donor_gain | 1.0000 |
| 15:96784256:GAAGG:G | donor_gain | 1.0000 |
| 15:96784258:AG:A | donor_gain | 1.0000 |
| 15:96784259:GG:G | donor_gain | 1.0000 |
| 15:96784260:G:GC | donor_loss | 1.0000 |
| 15:96784260:G:GG | donor_gain | 1.0000 |
| 15:96784261:T:G | donor_loss | 1.0000 |
| 15:96784994:A:AG | acceptor_gain | 1.0000 |
| 15:96784995:G:GG | acceptor_gain | 1.0000 |
| 15:96784995:GA:G | acceptor_gain | 1.0000 |
| 6:44343236:T:G | donor_gain | 1.0000 |
| 6:44352869:GTAGA:G | donor_gain | 1.0000 |
| 6:44352872:GA:G | donor_gain | 1.0000 |
| 6:44352874:G:GG | donor_gain | 1.0000 |
| 6:44360566:GACGA:G | donor_gain | 1.0000 |
| 6:44360569:GA:G | donor_gain | 1.0000 |
| 6:44360571:G:GG | donor_gain | 1.0000 |
| 6:44368497:AAT:A | donor_gain | 1.0000 |
| 6:44368498:AT:A | donor_gain | 1.0000 |
| 6:44368500:G:GG | donor_gain | 1.0000 |
| 6:44370049:A:AG | acceptor_gain | 1.0000 |
| 6:44370050:G:GG | acceptor_gain | 1.0000 |
| 6:44370050:GA:G | acceptor_gain | 1.0000 |
| 6:44370114:G:GG | donor_gain | 1.0000 |
| 15:96783515:G:T | donor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000149848 (6:44358026 G>A,C), RS1000170904 (6:44380553 T>C), RS1000174714 (6:44380105 G>A), RS1000260377 (6:44375876 C>T), RS1000345054 (6:44345439 C>T), RS1000365964 (6:44342996 G>A), RS1000446251 (6:44366820 T>C), RS1000523838 (6:44356444 T>G), RS1000531009 (6:44363245 A>G), RS1000817430 (6:44347571 A>G), RS1000862252 (6:44342756 A>C,G), RS1000909897 (6:44378933 G>T), RS1000910661 (6:44347270 T>C), RS1000955066 (6:44343981 T>A), RS1001027223 (6:44353755 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
19 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000253_23 | Attention deficit hyperactivity disorder and conduct disorder | 4.000000e-06 |
| GCST001762_426 | Obesity-related traits | 7.000000e-06 |
| GCST002463_21 | Systemic lupus erythematosus | 1.000000e-08 |
| GCST002652_13 | Cotinine glucuronidation | 4.000000e-08 |
| GCST003072_7 | Cerebrospinal fluid AB1-42 levels | 4.000000e-08 |
| GCST003123_30 | Severe influenza A (H1N1) infection | 4.000000e-12 |
| GCST003991_4 | Childhood ear infection | 4.000000e-14 |
| GCST004250_52 | Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) | 5.000000e-06 |
| GCST004862_118 | Itch intensity from mosquito bite adjusted by bite size | 9.000000e-06 |
| GCST005013_42 | Childhood ear infection | 3.000000e-14 |
| GCST007325_40 | General risk tolerance (MTAG) | 5.000000e-08 |
| GCST007576_208 | Chronotype | 8.000000e-09 |
| GCST007576_400 | Chronotype | 9.000000e-07 |
| GCST008513_29 | Health literacy | 3.000000e-06 |
| GCST009391_1671 | Metabolite levels | 7.000000e-06 |
| GCST009391_640 | Metabolite levels | 3.000000e-06 |
| GCST012145_7 | Ferritin levels | 8.000000e-06 |
| GCST012485_5 | Cerebral amyloid angiopathy x sex interaction in Alzheimer’s disease | 3.000000e-06 |
| GCST90000047_258 | Age at first sexual intercourse | 8.000000e-10 |
EFO canonical traits (16, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004620 | vitamin B12 measurement |
| EFO:0006508 | cotinine glucuronidation measurement |
| EFO:0004670 | beta-amyloid 1-42 measurement |
| EFO:1001488 | influenza A (H1N1) |
| EFO:0007904 | susceptibility to childhood ear infection measurement |
| EFO:0007965 | response to combination chemotherapy |
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0008579 | risk-taking behaviour |
| EFO:0008328 | chronotype measurement |
| EFO:0010104 | health literacy measurement |
| EFO:0010470 | carnosine measurement |
| EFO:0010504 | inositol measurement |
| EFO:0004459 | ferritin measurement |
| EFO:0008343 | sex interaction measurement |
| EFO:0009749 | age at first sexual intercourse measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Fulvestrant | decreases methylation | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Indomethacin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cerebral amyloid angiopathy, conduct disorder